A detailed history of Clark Financial Services Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Clark Financial Services Group Inc holds 2,730 shares of ABBV stock, worth $547,283. This represents 0.49% of its overall portfolio holdings.

Number of Shares
2,730
Previous 4,315 36.73%
Holding current value
$547,283
Previous $786,000 40.46%
% of portfolio
0.49%
Previous 0.95%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $245,342 - $286,504
-1,585 Reduced 36.73%
2,730 $468,000
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $1,917 - $2,185
-12 Reduced 0.28%
4,315 $786,000
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $11,008 - $12,397
-80 Reduced 1.82%
4,327 $671,000
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $12,156 - $14,073
-91 Reduced 2.02%
4,407 $656,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $3,445 - $4,287
26 Added 0.58%
4,498 $606,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $2,458 - $2,831
-17 Reduced 0.38%
4,472 $712,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $3,042 - $3,649
22 Added 0.49%
4,489 $725,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $3,623 - $4,156
-27 Reduced 0.6%
4,467 $600,000
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $2,507 - $3,111
-19 Reduced 0.42%
4,494 $729,000
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $11,924 - $15,088
111 Added 2.52%
4,513 $611,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $8,086 - $9,179
76 Added 1.76%
4,402 $475,000
Q2 2021

Aug 09, 2021

SELL
$105.21 - $117.21 $2,525 - $2,813
-24 Reduced 0.55%
4,326 $487,000
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $16,061 - $17,681
-157 Reduced 3.48%
4,350 $471,000
Q2 2020

Aug 12, 2022

BUY
$73.37 - $98.18 $330,678 - $442,497
4,507 New
4,507 $691,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clark Financial Services Group Inc Portfolio

Follow Clark Financial Services Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Financial Services Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Clark Financial Services Group Inc with notifications on news.